Related references
Note: Only part of the references are listed.Identification of Drug Transporter Genomic Variants and Inhibitors That Protect Against Doxorubicin-Induced Cardiotoxicity
Tarek Magdy et al.
CIRCULATION (2022)
CRISPR-based functional evaluation of schizophrenia risk variants
Prashanth Rajarajan et al.
SCHIZOPHRENIA RESEARCH (2020)
Unveiling the Role of the Most Impactful Cardiovascular Risk Locus through Haplotype Editing
Valentina Lo Sardo et al.
CELL (2018)
A Genetic Variant Associated with Five Vascular Diseases Is a Distal Regulator of Endothelin-1 Gene Expression
Rajat M. Gupta et al.
CELL (2017)
Pharmacogenomic screening for anthracycline-induced cardiotoxicity in childhood cancer
Folefac Aminkeng et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Validating the pharmacogenomics of chemotherapy-induced cardiotoxicity: What is missing?
Tarek Magdy et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children
Henk Visscher et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)